Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

NCT01502202 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

162

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non Small Cell Lung Cancer
Adenocarcinoma

Interventions

DRUG: Gefitinib
DRUG: Placebo
DRUG: Pemetrexed plusCIsplatin

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]